|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,034 INR | -0.47% |
|
-0.91% | +21.14% |
We would like to inform you that the Baddi manufacturing unit of
The European regulator has just issued a certificate of compliance for the facility stating that it complies with the principles and guidelines of Good Manufacturing Practice laid down in the directive 2003/94/EC which stipulates the requirements to fulfil GMP recommendations of WHO.
Contact:
Tel: +91 22 4018 9999
Fax: +91 22 4018 9986
(C) 2019 Electronic News Publishing, source
| 1st Jan change | Capi. | |
|---|---|---|
| +21.14% | 3.52B | |
| +17.88% | 44.31B | |
| +19.87% | 22.17B | |
| +13.05% | 14.62B | |
| +8.06% | 13.12B | |
| +39.21% | 11.58B | |
| -8.96% | 6.96B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.50% | 5.03B |
GLENMARK PHARMACEUTICALS LIMITED 
